{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T14:40:28Z","timestamp":1760712028126,"version":"build-2065373602"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Amiodarone and furosemide are frequently administered together in the intensive care unit, and their co-administration poses a risk of precipitation and catheter occlusion due to incompatibility. Thus, compatibility should be evaluated under clinically relevant conditions to ensure safe drug administration. This study investigated the impact of different mixing procedures on the physical compatibility of amiodarone and furosemide by employing two clinically relevant approaches: simulated mixing (SM) and route mixing (RM). Mixtures were prepared at therapeutic concentrations and evaluated by visual inspection, absorbance measurement, powder X-ray diffraction (PXRD), pH analysis, and particle size assessment. Although the drug ratios were identical, the RM samples displayed greater turbidity than the SM samples. The PXRD analysis showed no formation of new crystalline substances, and the precipitates consisted of known furosemide and amiodarone hydrochloride polymorphs. The pH shifted toward the alkaline range as the injection volume increased with furosemide dose. Importantly, differences in particle growth behavior were noted between SM and RM, with larger particles observed in the RM samples. In conclusion, mixing route significantly affects drug compatibility, with RM presenting a higher risk of precipitation. Assessing drug compatibility under clinically relevant conditions may help prevent catheter-related complications and improve the safety of intravenous pharmacotherapy.<\/jats:p>","DOI":"10.1038\/s41598-025-20217-0","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T14:27:00Z","timestamp":1760711220000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative evaluation of amiodarone and furosemide compatibility under different mixing conditions"],"prefix":"10.1038","volume":"15","author":[{"given":"So","family":"Iwabuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nango","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiki","family":"Nagatomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Miyagishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyofumi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Ootsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Kosuge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"20217_CR1","doi-asserted-by":"publisher","first-page":"652","DOI":"10.5507\/bp.2014.057","volume":"159","author":"O Machotka","year":"2015","unstructured":"Machotka, O., Manak, J., Kubena, A. & Vlcek, J. Incidence of intravenous drug incompatibilities in intensive care units. Biomed. Pap Med. Fac. Univ. Palacky Olomouc Czech Repub. 159, 652\u2013656. https:\/\/doi.org\/10.5507\/bp.2014.057 (2015).","journal-title":"Biomed. Pap Med. Fac. Univ. Palacky Olomouc Czech Repub."},{"key":"20217_CR2","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00228-023-03509-0","volume":"79","author":"LAF Wagner","year":"2023","unstructured":"Wagner, L. A. F., Neininger, M. P., Hensen, J., Zube, O. & Bertsche, T. Avoiding incompatible drug pairs in central-venous catheters of patients receiving critical care: an algorithm-based analysis and a staff survey. Eur. J. Clin. Pharmacol. 79, 1081\u20131089. https:\/\/doi.org\/10.1007\/s00228-023-03509-0 (2023).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"20217_CR3","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1345\/aph.1R414","volume":"47","author":"S Kanji","year":"2013","unstructured":"Kanji, S. et al. Inappropriate medication administration practices in Canadian adult icus: a multicenter, cross-sectional observational study. Ann. Pharmacother. 47, 637\u2013643. https:\/\/doi.org\/10.1345\/aph.1R414 (2013).","journal-title":"Ann. Pharmacother"},{"key":"20217_CR4","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1097\/CCM.0b013e3181e8adcc","volume":"38","author":"S Kanji","year":"2010","unstructured":"Kanji, S. et al. Systematic review of physical and chemical compatibility of commonly used medications administered by continuous infusion in intensive care units. Crit. Care Med. 38, 1890\u20131898. https:\/\/doi.org\/10.1097\/CCM.0b013e3181e8adcc (2010).","journal-title":"Crit. Care Med."},{"key":"20217_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.medin.2018.08.004","volume":"44","author":"G Castells Lao","year":"2020","unstructured":"Castells Lao, G., Rodr\u00edguez Reyes, M., Roura Turet, J., Prat Dot, M. & Soy Muner, D. L\u00f3pez cabezas, C. Compatibility of drugs administered as Y-site infusion in intensive care units: A systematic review. Med. Intensiva (Engl Ed). 44, 80\u201387. https:\/\/doi.org\/10.1016\/j.medin.2018.08.004 (2020).","journal-title":"Med. Intensiva (Engl Ed)"},{"key":"20217_CR6","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1177\/0148607190014003306","volume":"14","author":"DS Zaccardelli","year":"1990","unstructured":"Zaccardelli, D. S., Krcmarik, C. S., Wolk, R. & Khalidi, N. Stability of Imipenem and Cilastatin sodium in total parenteral nutrient solution. JPEN J. Parenter. Enter. Nutr. 14, 306\u2013309. https:\/\/doi.org\/10.1177\/0148607190014003306 (1990).","journal-title":"JPEN J. Parenter. Enter. Nutr."},{"key":"20217_CR7","doi-asserted-by":"publisher","first-page":"e609","DOI":"10.1542\/peds.2008-3080","volume":"123","author":"JS Bradley","year":"2009","unstructured":"Bradley, J. S., Wassel, R. T., Lee, L. & Nambiar, S. Intravenous ceftriaxone and calcium in the neonate: assessing the risk for cardiopulmonary adverse events. Pediatrics 123, e609\u2013e613. https:\/\/doi.org\/10.1542\/peds.2008-3080 (2009).","journal-title":"Pediatrics"},{"key":"20217_CR8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.accpm.2018.04.003","volume":"38","author":"M Benlabed","year":"2019","unstructured":"Benlabed, M. et al. Clinical implications of intravenous drug incompatibilities in critically ill patients. Anaesth. Crit. Care Pain Med. 38, 173\u2013180. https:\/\/doi.org\/10.1016\/j.accpm.2018.04.003 (2019).","journal-title":"Anaesth. Crit. Care Pain Med."},{"key":"20217_CR9","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.resuscitation.2020.09.003","volume":"156","author":"K Roedl","year":"2020","unstructured":"Roedl, K. et al. Epidemiology of intensive care unit cardiac arrest: characteristics, comorbidities, and post-cardiac arrest organ failure \u2014 A prospective observational study. Resuscitation 156, 92\u201398. https:\/\/doi.org\/10.1016\/j.resuscitation.2020.09.003 (2020).","journal-title":"Resuscitation"},{"key":"20217_CR10","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.resuscitation.2013.12.027","volume":"85","author":"I Efendijev","year":"2014","unstructured":"Efendijev, I., Nurmi, J., Castr\u00e9n, M. & Skrifvars, M. B. Incidence and outcome from adult cardiac arrest occurring in the intensive care unit: a systematic review of the literature. Resuscitation 85, 472\u2013479. https:\/\/doi.org\/10.1016\/j.resuscitation.2013.12.027 (2014).","journal-title":"Resuscitation"},{"key":"20217_CR11","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1056\/NEJM199909163411203","volume":"341","author":"PJ Kudenchuk","year":"1999","unstructured":"Kudenchuk, P. J. et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl. J. Med. 341, 871\u2013878. https:\/\/doi.org\/10.1056\/NEJM199909163411203 (1999).","journal-title":"N Engl. J. Med."},{"key":"20217_CR12","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1056\/NEJMoa013029","volume":"346","author":"P Dorian","year":"2002","unstructured":"Dorian, P. et al. Amiodarone as compared with Lidocaine for shock-resistant ventricular fibrillation. N Engl. J. Med. 346, 884\u2013890. https:\/\/doi.org\/10.1056\/NEJMoa013029 (2002).","journal-title":"N Engl. J. Med."},{"key":"20217_CR13","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1510\/icvts.2008.188656","volume":"7","author":"BPJ Leeuwenburgh","year":"2008","unstructured":"Leeuwenburgh, B. P. J., Versteegh, M. I. M., Maas, J. J. & Dunning, J. Should Amiodarone or Lidocaine be given to patients who arrest after cardiac surgery and fail to cardiovert from ventricular fibrillation? Interact. Cardiovasc. Thorac. Surg. 7, 1148\u20131151. https:\/\/doi.org\/10.1510\/icvts.2008.188656 (2008).","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"20217_CR14","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1097\/CCM.0000000000003276","volume":"46","author":"JA Silversides","year":"2018","unstructured":"Silversides, J. A. et al. Deresuscitation of patients with iatrogenic fluid overload is associated with reduced mortality in critical illness. Crit. Care Med. 46, 1600\u20131607. https:\/\/doi.org\/10.1097\/CCM.0000000000003276 (2018).","journal-title":"Crit. Care Med."},{"key":"20217_CR15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/s0927-7765(00)00195-8","volume":"20","author":"F Boury","year":"2001","unstructured":"Boury, F., Gautier, J. C., Bouligand, Y. & Proust, J. E. Interfacial properties of amiodarone: the stabilizing effect of phosphate anions. Colloids Surf. B Biointerfaces. 20, 219\u2013227. https:\/\/doi.org\/10.1016\/s0927-7765(00)00195-8 (2001).","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"20217_CR16","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1248\/yakushi.18-00004","volume":"138","author":"C Munakata","year":"2018","unstructured":"Munakata, C. et al. [Effect of pH and additives on the compatibility between Vancomycin and Furosemide injections.] (in Japanese). Yakugaku Zasshi. 138, 853\u2013860. https:\/\/doi.org\/10.1248\/yakushi.18-00004 (2018).","journal-title":"Yakugaku Zasshi"},{"key":"20217_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.enfi.2010.01.004","volume":"21","author":"E P\u00e9rez Juan","year":"2010","unstructured":"P\u00e9rez Juan, E., Maqueda Palau, M., Ar\u00e9valo Rubert, M., Ribas Nicolau, B. & Amor\u00f3s Cerd\u00e1, S. M. [Physical compatibility of Furosemide in intravenous mixtures for continuous perfusion.] (in Spanish). Enferm Intensiva. 21, 96\u2013103. https:\/\/doi.org\/10.1016\/j.enfi.2010.01.004 (2010).","journal-title":"Enferm Intensiva"},{"key":"20217_CR18","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/ajhp\/43.4.917","volume":"43","author":"S Campbell","year":"1986","unstructured":"Campbell, S., Nolan Jr, P. E., Bliss, M., Wood, R. & Mayersohn, M. Stability of Amiodarone hydrochloride in admixtures with other injectable drugs. Am. J. Hosp. Pharm. 43, 917\u2013921. https:\/\/doi.org\/10.1093\/ajhp\/43.4.917 (1986).","journal-title":"Am. J. Hosp. Pharm."},{"key":"20217_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejpb.2020.04.008","volume":"151","author":"F AlSalman","year":"2020","unstructured":"AlSalman, F., Howlett, M., Breatnach, C., Kelly, H. & O\u2019Brien, F. Supporting the use of sildenafil infusions in paediatric and neonatal intensive care \u2013 A compatibility study. Eur. J. Pharm. Biopharm. 151, 153\u2013161. https:\/\/doi.org\/10.1016\/j.ejpb.2020.04.008 (2020).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"20217_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/s0885-3924(98)00024-4","volume":"16","author":"KM Wilson","year":"1998","unstructured":"Wilson, K. M., Schneider, J. J. & Ravenscroft, P. J. Stability of Midazolam and Fentanyl in infusion solutions. J. Pain Symptom Manage. 16, 52\u201358. https:\/\/doi.org\/10.1016\/s0885-3924(98)00024-4 (1998).","journal-title":"J. Pain Symptom Manage."},{"key":"20217_CR21","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.clinthera.2020.06.005","volume":"42","author":"JN O\u2019Donnell","year":"2020","unstructured":"O\u2019Donnell, J. N., Xu, A. & Lodise, T. P. Intravenous compatibility of ceftazidime-avibactam and Aztreonam using simulated and actual Y-site administration. Clin. Ther. 42, 1580\u20131586e2. https:\/\/doi.org\/10.1016\/j.clinthera.2020.06.005 (2020).","journal-title":"Clin. Ther."},{"key":"20217_CR22","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1093\/ajhp\/34.9.939","volume":"34","author":"LV Allen Jr","year":"1977","unstructured":"Allen, L. V. Jr, Levinson, R. S. & Phisutsinthop, D. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets. Am. J. Hosp. Pharm. 34, 939\u2013943. https:\/\/doi.org\/10.1093\/ajhp\/34.9.939 (1977).","journal-title":"Am. J. Hosp. Pharm."},{"key":"20217_CR23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1136\/ejhpharm-2016-001038","volume":"24","author":"F Gersonde","year":"2017","unstructured":"Gersonde, F., Eisend, S., Haake, N. & Kunze, T. Physicochemical compatibility and emulsion stability of Propofol with commonly used analgesics and sedatives in an intensive care unit. Eur. J. Hosp. Pharm. 24, 293\u2013303. https:\/\/doi.org\/10.1136\/ejhpharm-2016-001038 (2017).","journal-title":"Eur. J. Hosp. Pharm."},{"key":"20217_CR24","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1109\/tbme.1983.325183","volume":"30","author":"BK Philip","year":"1983","unstructured":"Philip, B. K. & Philip, J. H. Characterization of flow in intravenous infusion systems. IEEE Trans. Biomed. Eng. 30, 702\u2013707. https:\/\/doi.org\/10.1109\/tbme.1983.325183 (1983).","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"20217_CR25","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1093\/ajhp\/45.11.2361","volume":"45","author":"JF Dasta","year":"1988","unstructured":"Dasta, J. F., Hale, K. N., Stauffer, G. L. & Tschampel, M. M. Comparison of visual and turbidimetric methods for determining short-term compatibility of intravenous critical-care drugs. Am. J. Hosp. Pharm. 45, 2361\u20132366. https:\/\/doi.org\/10.1093\/ajhp\/45.11.2361 (1988).","journal-title":"Am. J. Hosp. Pharm."},{"key":"20217_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jpainsymman.2004.02.002","volume":"27","author":"PD Good","year":"2004","unstructured":"Good, P. D., Schneider, J. J. & Ravenscroft, P. J. The compatibility and stability of Midazolam and dexamethasone in infusion solutions. J. Pain Symptom Manage. 27, 471\u2013475. https:\/\/doi.org\/10.1016\/j.jpainsymman.2004.02.002 (2004).","journal-title":"J. Pain Symptom Manage."},{"key":"20217_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1248\/yakushi.130.95","volume":"130","author":"Y Nakai","year":"2010","unstructured":"Nakai, Y., Tokuyama, E., Yoshida, M. & Uchida, T. Prediction of incompatibility of ceftriaxone sodium with calcium ions using the ionic product. Yakugaku Zasshi. 130, 95\u2013102. https:\/\/doi.org\/10.1248\/yakushi.130.95 (2010).","journal-title":"Yakugaku Zasshi"},{"key":"20217_CR28","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/jps.2600690533","volume":"69","author":"KA Shah","year":"1980","unstructured":"Shah, K. A., Das Gupta, V. & Stewart, K. R. Effect of pH, chlorobutanol, cysteine hydrochloride, Ethylenediaminetetraacetic acid, propylene glycol, sodium metabisulfite, and sodium sulfite on Furosemide stability in aqueous solutions. J. Pharm. Sci. 69, 594\u2013596. https:\/\/doi.org\/10.1002\/jps.2600690533 (1980).","journal-title":"J. Pharm. Sci."},{"key":"20217_CR29","doi-asserted-by":"publisher","first-page":"e16083","DOI":"10.1590\/s2175-97902017000216083","volume":"53","author":"AM Rubim","year":"2017","unstructured":"Rubim, A. M., Rubenick, J. B., Maurer, M., Laporta, L. V. & Rolim, C. M. B. Inclusion complex of Amiodarone hydrochloride with cyclodextrins: preparation, characterization and dissolution rate evaluation. Braz J. Pharm. Sci. 53, e16083. https:\/\/doi.org\/10.1590\/s2175-97902017000216083 (2017).","journal-title":"Braz J. Pharm. Sci."},{"key":"20217_CR30","doi-asserted-by":"publisher","first-page":"119679","DOI":"10.1016\/j.molliq.2022.119679","volume":"362","author":"HS Mohammadi","year":"2022","unstructured":"Mohammadi, H. S., Asl, A. H. & Khajenoori, M. Determination of Amiodarone hydrochloride solubility in pure and ethanol-modified subcritical water: experimental data and modeling. J. Mol. Liq. 362, 119679. https:\/\/doi.org\/10.1016\/j.molliq.2022.119679 (2022).","journal-title":"J. Mol. Liq"},{"key":"20217_CR31","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1002\/jps.22030","volume":"99","author":"GE Granero","year":"2010","unstructured":"Granero, G. E. et al. Biowaiver monographs for immediate release solid oral dosage forms: Furosemide. J. Pharm. Sci. 99, 2544\u20132556. https:\/\/doi.org\/10.1002\/jps.22030 (2010).","journal-title":"J. Pharm. Sci."},{"key":"20217_CR32","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1136\/ejhpharm-2015-000860","volume":"24","author":"MS Jacobs","year":"2017","unstructured":"Jacobs, M. S. et al. Ready-to-use parenteral amiodarone: a feasibility study towards a long-term stable product formulation. Eur. J. Hosp. Pharm. 24, 110\u2013114. https:\/\/doi.org\/10.1136\/ejhpharm-2015-000860 (2017).","journal-title":"Eur. J. Hosp. Pharm."},{"key":"20217_CR33","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ejps.2004.04.006","volume":"22","author":"CAS Bergstr\u00f6m","year":"2004","unstructured":"Bergstr\u00f6m, C. A. S., Luthman, K. & Artursson, P. Accuracy of calculated pH-dependent aqueous drug solubility. Eur. J. Pharm. Sci. 22, 387\u2013398. https:\/\/doi.org\/10.1016\/j.ejps.2004.04.006 (2004).","journal-title":"Eur. J. Pharm. Sci."},{"key":"20217_CR34","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jcis.2009.10.071","volume":"342","author":"L Benedini","year":"2010","unstructured":"Benedini, L. et al. Colloidal properties of Amiodarone in water at low concentration. J. Colloid Interface Sci. 342, 407\u2013414. https:\/\/doi.org\/10.1016\/j.jcis.2009.10.071 (2010).","journal-title":"J. Colloid Interface Sci."},{"key":"20217_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0021-9797(74)90018-6","volume":"46","author":"GJ Fleer","year":"1974","unstructured":"Fleer, G. J. & Lyklema, J. Polymer adsorption and its effect on the stability of hydrophobic colloids. II. The flocculation process as studied with the silver iodide-polyvinyl alcohol system. J. Colloid Interface Sci. 46, 1\u201312. https:\/\/doi.org\/10.1016\/0021-9797(74)90018-6 (1974).","journal-title":"J. Colloid Interface Sci."},{"key":"20217_CR36","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/0021-9797(76)90029-1","volume":"55","author":"GJ Fleer","year":"1976","unstructured":"Fleer, G. J. & Lyklema, J. Polymer adsorption and its effect on the stability of hydrophobic colloids. III. Kinetics of the flocculation of silver iodide sols. J. Colloid Interface Sci. 55, 228\u2013238. https:\/\/doi.org\/10.1016\/0021-9797(76)90029-1 (1976).","journal-title":"J. Colloid Interface Sci."},{"key":"20217_CR37","unstructured":"American Society of Health-System Pharmacists. Standardized concentrations: adult continuous IV infusions Version 1.01. (2016). https:\/\/www.ashp.org\/-\/media\/assets\/pharmacy-practice\/s4s\/docs\/s4s-iv-adult-continuous-infusion-guiding-principles.ashx"},{"key":"20217_CR38","unstructured":"Ballarat Health Services. Drug guideline furosemide (frusemide) - intravenous. (2025). https:\/\/www.bhs.org.au\/bhsapps\/govdoc\/gdhtml\/drg0009.html"},{"key":"20217_CR39","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1005419","volume":"364","author":"GM Felker","year":"2011","unstructured":"Felker, G. M. et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl. J. Med. 364, 797\u2013805. https:\/\/doi.org\/10.1056\/NEJMoa1005419 (2011).","journal-title":"N Engl. J. Med."},{"key":"20217_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/pharmaceutics13010021","volume":"13","author":"AK Koller","year":"2020","unstructured":"Koller, A. K., Krebs, S. & D\u00f6rje, F. Medication safety in intravenous therapy: A compatibility study of clonidine with drugs frequently used in intensive care. Pharmaceutics 13, 21. https:\/\/doi.org\/10.3390\/pharmaceutics13010021 (2020).","journal-title":"Pharmaceutics"},{"key":"20217_CR41","doi-asserted-by":"publisher","first-page":"348","DOI":"10.2146\/ajhp080059","volume":"66","author":"WN David","year":"2009","unstructured":"David, W. N. Drug incompatibility chemistry. Am. J. Health Syst. Pharm. 66, 348\u2013357. https:\/\/doi.org\/10.2146\/ajhp080059 (2009).","journal-title":"Am. J. Health Syst. Pharm."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20217-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20217-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20217-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T14:27:01Z","timestamp":1760711221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20217-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20217"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-20217-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable as the study design involved no humans or animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"36321"}}